NCT01489358View on ClinicalTrials.gov

Chikungunya Virus Vaccine Trial in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Viral VaccinesChikungunya FeverChikungunya Virus Infection
Interventions
BIOLOGICAL

VRC-CHKVLP059-00-VP

VRC-CHKVLP059-00-VP is a VLP vaccine that consists of the E1, E2 and capsid proteins of the Chikungunya Virus

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01489358 - Chikungunya Virus Vaccine Trial in Healthy Adults | Biotech Hunter | Biotech Hunter